U.S. Rep. Morgan Griffith (R-VA) and Rep. Angie Craig (D-MN) have reintroduced two bills in the U.S. House that would require the Food and Drug Administration to regulate hemp-derived CBD.

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 would subject hemp extract products to the regulatory framework for dietary supplements. Originally introduced in the House of Representatives in February 2021, it failed to leave the Energy and Commerce subcommittee on Health.

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 was re-introduced by Rep. Griffith along with 12 of the 46 original 2021-2022 cosponsors. 

Meanwhile, the CBD Product Safety and Standardization Act of 2023 would establish regulations for CBD as a food and beverage additive. It was originally introduced in December 2021 and also failed to leave the Energy and Commerce subcommittee on Health.

The bills’ filings follow the FDA’s recent announcement asking Congress to work with the agency to develop a regulatory framework for CBD. 

Griffith previously served as lead Republican sponsor on both bills. Former lead sponsors Kurt Schrader (D-OR) and Kathleen Rice (D-NY) have since retired. The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 was re-introduced by Rep. Griffith along with 12 of the 46 original 2021-2022 cosponsors. 

“The FDA has made it clear that legislative action by Congress is needed to solve its CBD regulatory problem, and these two bi-partisan bills re-introduced by Reps. Griffith and Craig serve as the solution,” said Jonathan Miller, U.S. Hemp Roundtable general counsel. “The FDA’s inaction over the past four years has had a devastating impact on U.S. hemp growers and has left thousands of unregulated products on the marketplace, raising health and safety concerns for consumers. The U.S. Hemp Roundtable is grateful to Rep. Griffith for his steadfast leadership on behalf of the hemp industry, and we are proud to work closely with him, Rep. Craig and other original co-sponsors on this critical legislation that is integral for hemp farmers, CBD producers and consumers,” said Jonathan Miller, U.S. Hemp Roundtable General Counsel.

"We commend the sponsors for introducing this important legislative package and urge Congress to pass all three bills without delay,” added National Cannabis Industry Association CEO Aaron Smith. “Doing so will bring about the much-needed clarity to small businesses across the country that responsibly produce health and wellness products and would establish a sensible regulatory framework to protect public safety and ensure consumers are well informed.”